首页 > 市场调查报告书 > 製药

个人化医学

市场调查报告书

商品编码

1477279

个人化医疗市场，按应用、按适应症、按最终用户、按地理位置

Personalized Medicine Market, By Application, By Indication, By End User, By Geography

出版日期: 2024年03月28日 | 出版商:

Coherent Market Insights | 英文 172 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计2024年全球个人化医疗市场价值为813.3亿美元，预计到2031年将达到1524亿美元，2024年至2031年年复合成长率（CAGR）为9.4%。

报告范围		报告详情
基准年：	2023年	2024 年市场规模：	813.3 亿美元
历史数据：	2019年至2023年	预测期：	2024年至2031年
预测 2024 年至 2031 年复合年增长率：	9.40%	2031 年价值预测：	1,524 亿美元

图 1. 2024 年个人化医疗市场占有率 (%)（按地区）

个人化医疗旨在根据每位患者的个别特征量身定制医疗保健，根据遗传学、生物标记和临床风险因素提供有针对性的治疗。它代表了从一刀切的治疗和疾病预防方法到考虑患者基因、环境和生活方式的个体差异的高度客製化系统的演变。个人化医疗有可能透过更明智的医疗决策来减少药物不良反应、提高治疗效果并改善健康结果。随着基因检测、巨量资料分析和分子诊断的进步，医生能够从基因上分析患者对特定疾病的易感性，并相应地优化治疗。这个新兴领域正在改变个人层面上疾病的诊断、治疗和预防方式。

市场动态：

个人化医疗市场的推动因素包括製药公司的医疗保健成本和药物开发成本不断上升、对标靶治疗的需求不断增加、伴随诊断的日益突出、对精准医疗的日益关注以及用于研究的遗传资料的可用性。然而，患者和医生缺乏对这种方法的认识、高昂的前期成本以及监管问题阻碍了该市场的成长。发展新兴经济体的医疗基础设施为市场参与者提供了巨大的成长机会。市场领导者正在投资巨量资料分析，并与诊断测试公司合作开发组合产品，以改善患者的治疗效果。药物基因组学和伴随诊断的持续研究将在未来十年进一步扩大个人化医疗的能力。

研究的主要特点：

该报告对全球个人化医疗市场进行了深入分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
它阐明了不同细分市场的潜在收入成长机会，并解释了该市场有吸引力的投资主张矩阵。
这项研究还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采取的竞争策略的重要见解。
它根据以下参数描述了全球个人化医疗市场的主要参与者——公司亮点、产品组合、主要亮点、财务表现和策略。
该报告的见解将使行销人员和公司管理当局能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
全球个人化医疗市场报告迎合了该行业的各个利益相关者，包括投资者、供应商、产品製造商、分销商、新进业者和财务分析师。
利害关係人可以透过用于分析全球个人化医疗市场的各种策略矩阵轻鬆做出决策。

介绍
北美洲
我们
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地区
欧洲
英国
德国
义大利
法国
西班牙
俄罗斯
欧洲其他地区
亚太地区
中国
印度
日本
东协
澳洲
韩国
亚太地区其他地区
中东
海湾合作委员会
以色列
中东其他地区
非洲
北非
中非
南非

第 9 章：竞争格局

公司简介
- Precision Biologics
- Danaher Corporation
- Abbott
- Illumina, Inc.
- Exact Sciences Corporation
- ASURAGEN, INC.
- Exagen Inc.
- Genentech, Inc.
- Berg Health
- Omada Health
- Natera
- Invitae
- Myriad Genetics
- Celcuity
- InsightRX
- Axial3D

第 10 章：分析师观点

命运之轮
分析师观点
连贯的机会图

第 11 章：参考文献与研究方法

参考
研究方法论

简介目录

Product Code: CMI6807

The global personalized medicine market is estimated to be valued at USD 81.33 Bn in 2024 and is expected to reach USD 152.40 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 9.4% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 81.33 Bn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	9.40%	2031 Value Projection:	US$ 152.4 Bn

Figure 1.Personalized Medicine Market Share (%), By Region, 2024

Personalized medicine aims to tailor healthcare to the individual characteristics of each patient, providing targeted treatment based on genetics, biomarkers, and clinical risk factors. It represents an evolution from a one-size-fits-all approach to treatment and disease prevention to a highly customized system that considers individual variability in patients' genes, environments, and lifestyles. Personalized medicine has the potential to reduce adverse drug reactions, enhance treatment efficacy, and improve health outcomes through better-informed medical decisions. With advancements in genetic testing, big data analytics and molecular diagnostics, it enables physicians to genetically profile patients' susceptibility to specific diseases and optimize therapies accordingly. This emerging field is transforming how diseases are diagnosed, treated, and prevented on an individual level.

Market Dynamics:

The personalized medicine market is driven by factors such as rising healthcare costs and drug development costs for pharmaceutical companies, increasing demand for targeted therapies, growing prominence of companion diagnostics, rising focus on precision medicine, and availability of genetic data for research. However, lack of awareness about this approach among patients and physicians, high upfront costs, and regulatory issues hinder the growth of this market. Developing healthcare infrastructure in emerging economies provides significant growth opportunities for market players. Market leaders are investing in big data analytics and collaborating with diagnostic testing companies to develop combination products for better patient outcomes. Continued research in pharmacogenomics and companion diagnostics will further expand the capabilities of personalized medicine over the next decade.

Key Features of the Study:

This report provides an in-depth analysis of the global personalized medicine market, and provides market size (USD BN) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global personalized medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study includes Precision Biologics, Danaher Corporation, Abbott, Illumina, Inc., Exact Sciences Corporation, ASURAGEN, INC., Exagen Inc., Genentech, Inc., Berg Health, Omada Health, Natera, Invitae, Myriad Genetics, Celcuity, InsightRX, and Axial3D
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global personalized medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global personalized medicine market

Detailed Segmentation-

Application:
- Therapeutics
- Nutrition & Wellness
- Diagnostics
- Others
Indication:
- Oncology
- Immunology
- Neurology
- Cardiology
- Autoimmune Diseases
- Others
End User:
- Hospital & Clinics
- Diagnostic Laboratories
- Academic & Research Institutes
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Precision Biologics
- Danaher Corporation
- Abbott
- Illumina, Inc.
- Exact Sciences Corporation
- ASURAGEN, INC.
- Exagen Inc.
- Genentech, Inc.
- Berg Health
- Omada Health
- Natera
- Invitae
- Myriad Genetics
- Celcuity
- InsightRX
- Axial3D

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Application
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Technology Overview
Regulatory Scenario
Pricing Analysis
PEST Analysis

4. Global Personalized Medicine Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 Impact on the market

5. Global Personalized Medicine Market, By Application, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Therapeutics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Nutrition & Wellness
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Diagnostics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

6. Global Personalized Medicine Market, By Indication, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Immunology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Autoimmune Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

7. Global Personalized Medicine Market, By End User, 2019 - 2031, (USD BN)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospital & Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Diagnostic Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Academic & Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD BN)

8. Global Personalized Medicine Market, By Region, 2019 - 2031, (USD BN)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD BN)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD BN)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD BN)
North Africa
Central Africa
South Africa

9. Competitive Landscape

Company Profiles
- Precision Biologics*
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
- Danaher Corporation
- Abbott
- Illumina, Inc.
- Exact Sciences Corporation
- ASURAGEN, INC.
- Exagen Inc.
- Genentech, Inc.
- Berg Health
- Omada Health
- Natera
- Invitae
- Myriad Genetics
- Celcuity
- InsightRX
- Axial3D